Are there Challenges in Using Recombinant Growth Factors?
Despite their potential, there are challenges in using recombinant growth factors. One major issue is the short half-life of these proteins, which may require controlled release systems for sustained activity. There's also the risk of inducing unwanted cell proliferation, posing a risk of tumorigenesis. Furthermore, the high production costs can limit their widespread clinical application.
